Catalent

Catalent is a global leader dedicated to empowering pharmaceutical, biotechnology, and consumer health partners worldwide. As a premier Contract Development and Manufacturing Organization (CDMO), Catalent excels in optimizing product development, launch, and full life-cycle supply for patients. The company leverages extensive expertise across development sciences, advanced delivery technologies, and multi-modality manufacturing to support a diverse range of therapeutic areas. This comprehensive approach makes Catalent a preferred partner for personalized medicines, blockbuster drugs, and innovative consumer health brand extensions, driving forward global health solutions.

With a broad portfolio of products and services, Catalent offers critical capabilities including drug delivery technology, comprehensive packaging solutions, cold chain storage, and sophisticated supply chain management. The company operates across 39 locations globally, supported by an extensive workforce of over 10,000 employees. This vast operational footprint and skilled team enable Catalent to provide end-to-end development and manufacturing services, from early-stage clinical supply to commercial production. Meet Catalent's team to understand the expertise driving their innovative solutions and commitment to quality.

Catalent reported significant revenue of $4.38B, underscoring its substantial market presence. The company competes within a dynamic landscape of pharmaceutical and healthcare service providers, including major players like Patheon Pharma Services and West Pharmaceutical Services. Its strategic focus on advanced manufacturing and drug delivery technologies positions it for continued growth. Learn about Catalent's global headquarters for insights into its operational centers and geographic reach. For a deeper understanding of its financial performance and market standing, Explore financial highlights to review key metrics and trends.